ICMR drops Ivermectin, HCQ from COVID-19 treatment guidelines

2 min read
Revised guidelines point to risk of adverse reaction in combination azithromycin
The Indian Council of Medical Research-led COVID-19 National Task Force has dropped the use of the drugs ivermectin and hydroxychloroquine (HCQ) from the revised "clinical guidance for management of adult COVID-19 patients".

The revised guidelines also suggests the use of drugs Remdesivir and Tocilizumab in specific circumstances.

While stressing the need to wear masks, maintain distancing and hand hygiene, the guidelines added that symptomatic patients may take antipyretic and multivitamins and seek immediate medical attention if they experience difficulty in breathing or high-grade fever or severe cough, particularly if lasting for more than five days.

The All India Institute of Medical Sciences (AIIMS) and the Indian Council of Medical Research (ICMR)…
Special Correspondent
Read full article